NSG
AMGN icon

Nalls Sherbakoff Group’s Amgen AMGN Stock Holding History

Nalls Sherbakoff Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.15K Hold
4
– – ﹤0.01% 386
2023
Q3 		$1.08K Hold
4
– – ﹤0.01% 396
2023
Q2 		$883 Hold
4
– – ﹤0.01% 421
2023
Q1 		$966 Buy
+4
New +$982 ﹤0.01% 440

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nalls Sherbakoff Group's AMGN Position: Q4 2023 in Review

Nalls Sherbakoff Group held its Amgen (AMGN) position steady in Q4 2023 at 4 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Nalls Sherbakoff Group first reported a position in AMGN in Q1 2023 and has held it in 4 quarters since. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Nalls Sherbakoff Group held 4 shares of Amgen worth $1.15K as of Q4 2023.
  • Nalls Sherbakoff Group left its Amgen share count unchanged in Q4 2023.
  • Amgen made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2023, its #386 holding.
  • Nalls Sherbakoff Group first reported a position in Amgen in Q1 2023 and has held it in 4 quarters since.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2023, filed 9 Apr 2024.